88 results
SC TO-T
EX-99
BMY
Bristol-Myers Squibb Co.
25 Jan 24
Third party tender offer statement
8:13am
) certain anti-corruption and anti-money laundering matters; (t) regulatory matters; and (u) financial advisors.
In the Merger Agreement, Purchaser
8-K
EX-10.1
BMY
Bristol-Myers Squibb Co.
4 May 21
Departure of Directors or Certain Officers
4:16pm
understand that you may contact the International Compensation and Benefits Group.
Anti-Corruption Information. Anti-corruption laws prohibit certain
8-K
EX-10.4
zj1g3
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.3
wn534yhdev75
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.5
ok1h9c23 2gb0xv2j
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.2
mu4obxt3 licd
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
602nr40y7g i5r48l2
6 Nov 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
bvb4sjfjx2ppcx
6 Nov 20
Entry into a Material Definitive Agreement
8:00am
SC TO-T
EX-99
b1svppb9ki
19 Oct 20
Third party tender offer statement
6:03am